Legend Biotech

Legend Biotech FCF per Share

The Free Cash Flow per Share of Legend Biotech (LEGN) as of Oct 11, 2026 is -0.91 USD. In the previous year, Free Cash Flow per Share was -0.86 USD — a change of 5.18% (lower).

FCF per Share

-0.91USD

YoY

5.18%

Last updated:

Free Cash Flow per Share of Legend Biotech is 2025 -0.91 USD. Free Cash Flow per Share of Legend Biotech was 2024 -0.86 USD. It decreases by 5.18% lower compared to the previous year.

The Legend Biotech FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
2.87 USD
Jan 1, 2019
-1.22 USD
Jan 1, 2020
-1.91 USD
Jan 1, 2021
-1.66 USD
Jan 1, 2022
-1.41 USD
Jan 1, 2023
-2.29 USD
Jan 1, 2024
-0.86 USD
Jan 1, 2025
-0.91 USD
The Legend Biotech FCF per Share history
YEARFCF per ShareYoY
-0.91USD+5.18%
-0.86USD-62.18%
-2.29USD+62.69%
-1.41USD-15.50%
-1.66USD-13.07%
-1.91USD+56.89%
-1.22USD-142.55%
2.87USD-11,697.01%
-0.02USD—
Access this data via the Eulerpool API
Get Free API Key

Legend Biotech Stock analysis

What does Legend Biotech do? Legend Biotech Corp is a leading biopharmaceutical company specializing in the discovery and development of innovative cell therapies for the treatment of serious diseases such as cancer. The company was founded in 2015 as a subsidiary of Genscript Biotech Corp and is headquartered in Somerset, New Jersey, USA. Additionally, the company also operates locations in China and Europe. Legend Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Legend Biotech stock

Free Cash Flow per Share of Legend Biotech is -0.91 USD in 2025.

Free Cash Flow per Share of Legend Biotech changed from -0.86 USD to -0.91 USD, representing a 5.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Legend Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Legend Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Legend Biotech